Postponement and distribution from a single source
Arvato Healthcare has official authorisations from the EU for packaging, repackaging and labelling of medicines, and combines distribution and manufacturing at a single production site (Directive 2001/83/EC). Products are stored in a country-neutral condition, and just before shipment are provided with country-specific labels and package inserts by specially trained personnel in a strictly isolated, temperature and access-controlled area. Thanks to multi-user infrastructures, costs can be saved both for mass production and small batches.
Pharmaceutical companies profit from synchronisation of the postponement solutions with existing processes in the areas of logistics, sales, production and transport.
We take great pride in our quality. That is why all our repacking and labelling processes take place in compliance with strict standards in special, access-controlled areas.Carsten Thiemt, Head of Quality, arvato Healthcare